Client Handout · Birth & Newborn Series
The Newborn Hour
Eight decisions made in the first 48 hours — most before you’ve slept, some before you’ve held your baby
In the first hours of your baby’s life, more medical decisions are made than at any other point in childhood — most of them presented as standard procedures rather than choices. This handout covers each one: what it is, what is typically not disclosed, whether it can be delayed or declined, and what to ask before the hospital visit rather than during it.
Before the procedures begin — cord clamping
The umbilical cord continues to pulse for 3–5 minutes after birth, transferring blood from the placenta to the baby. This blood contains approximately
80–100 mL — roughly a third of the baby’s total blood volume at birth — along with stem cells, iron stores for the first 6 months, and immune cells. Immediate cord clamping (within 15–30 seconds) cuts this transfer short. WHO guidelines recommend waiting until pulsation stops; most US hospitals clamp within 60 seconds. Ask for
physiological third stage — wait until the cord stops pulsing — in your birth plan before admission. This is the single highest-value, lowest-risk intervention in the newborn period.
What it is: 1 mg phytonadione (synthetic Vitamin K1) injected intramuscularly to prevent Vitamin K Deficiency Bleeding (VKDB) — a rare but potentially fatal bleeding disorder. The risk is real: VKDB can cause intracranial hemorrhage. This is not a trivial risk to decline without a plan.
What is typically not disclosed
-
■
The 1 mg dose delivers 100–500× adult physiological plasma concentrations of Vitamin K1 into a newborn liver that has not yet developed full metabolic capacity. Effects on Vitamin K-dependent proteins beyond coagulation — including bone metabolism, arterial calcification prevention, and cell growth signaling — have not been studied at this dose in neonates.
-
■
Standard multi-dose formulations contain benzyl alcohol (0.9 mg/dose as preservative). Benzyl alcohol accumulates in premature and low-birth-weight neonates whose glycine conjugation is immature — causing “gasping syndrome” (metabolic acidosis, CNS depression, death). FDA warned about benzyl alcohol in neonatal medications in 1982. Preservative-free formulations exist and should be requested.
-
■
Other excipients include polysorbate 80 (some formulations) and propylene glycol. Polysorbate 80 is associated with rare anaphylaxis; propylene glycol is metabolized to lactic acid, relevant in neonates with immature metabolic clearance.
-
■
An oral Vitamin K alternative exists: a 3-dose oral protocol (at birth, 1 week, 1 month) used in the Netherlands, Norway, and other European countries. It is not FDA-approved as a pharmaceutical in the US, which is why IM injection is standard — not because oral is ineffective. Formula-fed infants are not at significant VKDB risk because formula is Vitamin K-fortified.
Questions to ask
- Can I receive the preservative-free formulation specifically? (No benzyl alcohol.)
- Is the oral Vitamin K protocol available at this facility or through a willing provider?
- If I breastfeed exclusively, can maternal Vitamin K status and diet reduce the dose needed?
What it is: Antibiotic ointment applied to both eyes within the first hour of life to prevent ophthalmia neonatorum — eye infection from gonorrhea or chlamydia contracted during vaginal delivery. Mandated by law in most US states.
What is typically not disclosed
-
■
The original indication was gonorrheal ophthalmia, which causes blindness. If you have been screened and tested negative for gonorrhea and chlamydia — which is standard prenatal care — your baby has no exposure route for these organisms at a vaginal delivery. The prophylaxis is applied universally regardless of maternal STI status.
-
■
The ointment blurs and irritates newborn vision for 1–2 hours after application. The first hour of life is the most neurobiologically timed bonding window in human development: eye contact in this window triggers oxytocin release in both mother and infant. Erythromycin interrupts this during its only available occurrence.
-
■
Some states allow signed informed refusal; others have no refusal provision. This is a conversation to have before labor, not in the delivery room. Ask your provider and your state law before your due date.
Questions to ask
- I have tested negative for gonorrhea and chlamydia this pregnancy. Does my state allow informed refusal of this ointment, and what is the form?
- If the ointment is legally required, can application be delayed until after the first hour of skin-to-skin contact?
What it is: The first dose of a 3-dose Hepatitis B vaccine series, administered within 24 hours of birth as standard US practice regardless of maternal HBsAg status. Contains recombinant HBsAg produced in yeast, aluminum adjuvant, and yeast protein residuals.
What is typically not disclosed
-
■
If the mother is HBsAg-negative (not carrying Hepatitis B), the day-of-birth dose carries no acute infectious rationale. The infant’s only risk of Hepatitis B before age 10 is from an infected mother at birth. The day-of-birth dose in HBsAg-negative births is for schedule adherence. Delaying to the standard 2-month visit carries no clinical risk in these cases.
-
■
The neonatal dose (Engerix-B or Recombivax HB) contains 250 mcg of aluminum adjuvant. A newborn weighing 3–4 kg receiving 250 mcg aluminum has an exposure equivalent — weight-adjusted — to approximately 3,500–4,500 mcg in an average adult. The neonatal blood-brain barrier is not fully formed. Renal aluminum clearance is immature. No safety study has characterized aluminum accumulation and clearance in neonates from this administration.
-
■
The package insert (Section 13.1) states: “This vaccine has not been evaluated for its carcinogenic or mutagenic potential, or its potential to impair fertility.” These studies were never required as a condition of FDA approval.
Questions to ask
- I am HBsAg-negative. What is the clinical rationale for the day-of-birth dose specifically, rather than waiting until the 2-month visit?
- What is the aluminum content of the specific brand being used, and what is known about neonatal aluminum clearance at this dose?
- Can I see the package insert for the specific lot before administration?
What it is: A blood sample taken from the baby’s heel to screen for PKU (phenylketonuria) and a panel of metabolic, endocrine, and hemoglobin disorders — between 29 and 55 conditions depending on state. For conditions like PKU that require dietary intervention from birth, early detection is genuinely life-altering. PKU itself affects approximately 1 in 15,000–25,000 newborns.
Blood spot storage — the undisclosed part
The dried blood spot card (Guthrie card) is stored by the state health department after testing. Storage duration varies by state: some store indefinitely, others for 21 years or longer. In multiple documented cases, state programs have shared blood spots with law enforcement agencies and commercial researchers without specific parental notification or consent. Several states allow parents to request destruction of stored samples after testing is complete, or to opt out of long-term storage while still completing the medical screen. This is almost never disclosed at the time of the test.
Your options
-
■
Accept the screen: The medical value is real for conditions like congenital hypothyroidism, PKU, and MCAD deficiency. Early detection enables treatment that prevents permanent disability.
-
■
Accept the screen, request blood spot destruction: Many states allow you to complete the testing and then request that stored samples be destroyed. Contact your state health department before the birth to understand your specific options.
-
■
Request delay: Testing is more accurate after the first 24 hours of feeding. Some parents request the test be done before hospital discharge rather than in the first hours, to protect the initial bonding period.
-
■
Decline: Parents may decline the screen in most states with signed refusal. If declining, understand which conditions are being screened and have a follow-up monitoring plan for conditions like congenital hypothyroidism that are otherwise asymptomatic in the newborn period.
Questions to ask before the birth
- What does my state’s law require regarding blood spot storage, third-party access, and parental right to request destruction?
- Can the heel prick be delayed until after the first bonding period rather than performed in the first hours?
- What pain mitigation protocol does this hospital use during the heel prick? (Sucrose, skin-to-skin, and non-nutritive sucking all reduce neonatal pain response.)
What it is: A non-invasive screen using otoacoustic emissions (OAE) or auditory brainstem response (ABR) to detect hearing loss before discharge. Mandated in all 50 states. OAE places a small speaker and microphone in the ear canal; ABR uses electrodes to measure neural response. The test is typically performed while the baby sleeps.
What is typically not disclosed
-
■
False positive rate: OAE screening in the first 24 hours has a refer (fail) rate of 4–8%, frequently because amniotic fluid in the ear canal causes acoustic interference — not hearing loss. Most “refer” results in healthy newborns resolve on repeat testing at the pediatrician. A refer result should trigger follow-up, not immediate diagnostic certainty.
-
■
Consent: The screen is typically performed without explaining what is happening or asking permission. Most parents do not know it occurred until after the fact. Knowing it is planned allows you to be present and aware.
-
■
Timing: The screen is often scheduled during the first 24 hours — when fluid interference is highest and the false positive rate is highest. Requesting the screen be done closer to discharge (48 hours) or on an outpatient basis reduces unnecessary referrals.
Questions to ask
- Can the hearing screen be scheduled at 48 hours rather than 24 hours to reduce the fluid-related false positive rate?
- If the screen returns a refer result, what is the follow-up protocol before an ABR diagnostic test is ordered?
What it is: A non-invasive pulse oximetry reading on the right hand and one foot to detect low oxygen saturation that may indicate critical congenital heart disease. Among the least controversial newborn procedures — non-invasive, no needles, no stored samples. A positive screen (low oxygen) triggers echocardiogram for confirmation.
-
■
Best performed after 24 hours of age — earlier testing has higher false positive rates as fetal circulation patterns normalize. Some hospitals screen at 12 hours; requesting delay to 24+ hours is reasonable.
-
■
Among the genuinely low-burden newborn screens. Critical CHD affects approximately 1 in 100 newborns; early detection allows surgical planning before cardiac failure. This is one screening with a strong benefit-to-burden ratio.
Circumcision is the surgical removal of the foreskin — a procedure typically performed in the first 24–48 hours of life, while the mother is still recovering from labor, without the patient’s knowledge or consent, and in most US hospitals without adequate analgesia. It is performed at this timing by convention, not medical necessity. It does not need to happen before you leave the hospital. If you choose it for your child — for religious, cultural, or personal reasons — it can happen later, when you have had time to process the decision.
Medical consensus
No major medical organization — not the AAP, not the WHO, not the ACOG — recommends routine circumcision as medically necessary. The AAP’s position is that “the health benefits of newborn circumcision outweigh the risks” but are “not great enough to recommend routine circumcision.” The Royal Dutch Medical Association, British Medical Association, and Danish Medical Society have all stated that routine infant circumcision is not in the child’s best interest and constitutes a violation of bodily autonomy.
What is removed
The foreskin contains approximately 20,000 specialized nerve endings — including Meissner’s corpuscles, the primary mechanoreceptors for fine-touch sensation. It functions as a protective mucosal layer for the glans and as the tissue through which a significant portion of sexual sensation is mediated. Its removal is the permanent loss of functional tissue.
Pain — what is typically used and what is adequate
Most US circumcisions are performed with EMLA cream (topical anesthetic) or dorsal penile nerve block. EMLA alone is inadequate for surgical procedures — it reduces surface sensation but does not reach the deep tissue involved in foreskin removal. Full ring block (circumferential injection) is more effective but not universally used. A significant proportion of hospital circumcisions are performed with insufficient or no analgesia — a practice that, in any other surgical context, would constitute a violation of the standard of care.
Taddio et al. (Lancet, 1997) documented that infants circumcised without adequate analgesia showed significantly heightened pain responses to subsequent vaccine injections for months afterward — indicating that the pain of circumcision creates lasting sensitization of the neonatal pain response system.
If you are considering circumcision
- Does this decision need to be made in the hospital within 48 hours? (It does not. Circumcision can be performed at any age.)
- What analgesia protocol will be used? Will a full ring block be performed, not just EMLA cream?
- Who will perform the procedure, and what is their complication rate? (Physician complication rates vary significantly.)
- If the decision is religious or cultural: do you want to take time to research, discuss, and decide — outside the hospital, after recovery?